Sonio will leverage the NEXT French Healthcare programme to land on the North American market.
Organized by Business France in partnership with Bpifrance, and supported by two competitiveness clusters, Medicen Paris Region and Lyonbiopôle, the NEXT French Healthcare programme selects the best innovative French e-health and MedTech companies wishing to enter the North American market. On May 11, 2021, Sonio was selected after deliberations by the selection committees along with 13 other French e-health and MedTech startups.
NEXT French Healthcare programme will enable Sonio to meet leaders in the healthcare industry to gain visibility and establish key partnerships. Meanwhile, Sonio will also benefit from the support and experience of advisors from Business France’s offices in New York, Chicago and Montreal.
Beyond the commercial aspects, the NEXT French Health programme also represents an opportunity for Sonio to better refine its strategy regarding the regulatory aspects and clinical validation of its products and services for the U.S. market, including Sonio Diagnostics, an Artificial Intelligence software to help diagnose fetal anomalies and associated pathological syndromes, and Sonio Screening, a SaaS solution that secures prenatal screening examinations by making them even more complete, structured, and augmented according to risk factors.